146: With over a decade of extensive experience in biotechnology and life science space, now leading a pharmaceutical company for over a year, growing market cap from less than $10 million to over $16 million and from 2 to 24 FTEs. (Punit Dhillon) fte 21-30 healthcare podcast sales $5m-$10m aud usa Oct 06, 2021

In this episode, I interview Punit Dhillon, the President, CEO & Chair of Skye Bioscience Inc. based in San Diego, California, USA, a public pharmaceutical company with a leading program in ophthalmology, developing a drug for glaucoma. Punit is a biotech and life sciences entrepreneur...

Continue Reading...
057: Left a $220k corporate biotech job to start a business in 2014 aged 48, with a massive mortgage. Business partner got sick, never returned so sold for $1m to a listed company. Office across from her kids’ school. 2 FTE to 6 (Michelle Gallaher) australia fte 6-10 healthcare podcast sales <$0.5m aud Nov 25, 2020

In this episode, I interview Michelle Gallaher, a Melbourne-based award-winning entrepreneur, speaker, and advocate for the Australian health technology sector and for women in science, technology, engineering maths, and medicine (STEMM). As CEO of Opyl Ltd (ASX:OPL), a company...

Continue Reading...